Private company

DermTech, Inc.

American medical laboratories services company, incorporated in Delaware. Summary from the record

Last updated Oct 19, 2026.

Overview

IndustryServices-Medical Laboratories¹
HeadquartersSan Diego, California¹
Incorporated inDE²
Business address12340 El Camino Real, San Diego, Ca 92130²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Unless specifically noted otherwise, as used throughout this Business section, “we,” “our,” “us,” or the “Company” refers to the business, operations and financial results of DermTech Operations prior to, and the Company and its subsidiaries subsequent to, the completion of the Business Combination as the context requires. “Constellation” refers to the Company prior to the completion of the Business Combination.³ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

1.8%Gross margin⁴

-678.2%Operating margin⁴

-659.6%Net margin⁴

5.4%Revenue growth, 2023⁴

-176.5%Return on equity⁴

-$77.9MFree cash flow⁴

Where the money goes

Where each dollar of revenue went, fiscal 2023

Cost of revenueResearch and development

Cost of revenue50¢$15.0M
Research and development50¢$15.2M

Out of $15.3M in revenue.⁴ The company lost money this year.

Financial statements

Revenue⁵⁶⁷⁴$15.3M in 2023+526% since 2018

Gross profit⁵⁶⁷⁴$276.0K in 2023

Operating income⁸⁵⁶⁷⁴-$103.7M in 2023+172898233% since 2017

Net income⁸⁵⁶⁷⁴-$100.9M in 2023+168146567% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Revenue		$2.4M⁵	$3.4M⁶	$5.9M⁶	$11.8M⁷	$14.5M⁴	$15.3M⁴
Cost of revenue		$2.6M⁵	$3.3M⁶	$6.0M⁶	$10.6M⁷	$13.9M⁴	$15.0M⁴
Gross profit		-$185.0K⁵	$60.0K⁶	-$96.0K⁶	$1.3M⁷	$647.0K⁴	$276.0K⁴
Research and development		$2.1M⁵	$2.5M⁶	$5.3M⁶	$16.3M⁷	$24.1M⁴	$15.2M⁴
Operating expenses					$78.7M⁷	$118.8M⁴	$104.0M⁴
Operating income	-$60⁸	-$8.6M⁵	-$17.6M⁶	-$35.3M⁶	-$77.4M⁷	-$118.2M⁴	-$103.7M⁴
Net income	-$60⁸	-$10.0M⁵	-$20.1M⁶	-$36.5M⁶	-$78.3M⁷	-$116.7M⁴	-$100.9M⁴
Earnings per share					-$2.71⁷	-$3.88⁴	-$3.09⁴
Earnings per share (diluted)					-$2.71⁷	-$3.88⁴	-$3.09⁴
Shares (weighted, basic)					28.9M shares⁷	30.0M shares⁴	32.6M shares⁴
Shares (weighted, diluted)					28.9M shares⁷	30.0M shares⁴	32.6M shares⁴

Total assets⁸⁵¹²⁶⁷⁴$121.9M in 2023+62511% since 2017

Total liabilities⁸⁵⁶⁷⁴$64.8M in 2023+37432% since 2017

Shareholders’ equity⁵⁶⁷⁴$57.2M in 2023

Cash¹³⁶⁷⁴$36.7M in 2023+146864% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Cash	$25.0K¹³	$4.8M⁶	$15.4M⁶	$24.2M⁶	$176.9M⁷	$77.8M⁴	$36.7M⁴
Receivables					$3.8M⁷	$4.2M⁴	$2.6M⁴
Inventory					$480.0K⁷	$1.8M⁴	$1.0M⁴
Current assets	$25.0K⁸	$5.4M⁵	$17.1M¹²	$66.9M⁶	$232.8M⁷	$136.0M⁴	$61.8M⁴
Property, plant and equipment					$4.5M⁷	$6.4M⁴	$5.0M⁴
Total assets	$194.7K⁸	$5.7M⁵	$18.2M¹²	$69.8M⁶	$248.3M⁷	$202.1M⁴	$121.9M⁴
Accounts payable					$2.9M⁷	$2.4M⁴	$1.5M⁴
Current liabilities	$172.5K⁸	$10.5M⁵	$5.7M¹²	$5.4M⁶	$12.2M⁷	$15.6M⁴	$13.4M⁴
Total liabilities	$172.5K⁸	$11.0M⁵	$6.3M⁶	$7.9M⁶	$18.6M⁷	$69.7M⁴	$64.8M⁴
Retained earnings					-$206.4M⁷	-$323.0M⁴	-$423.9M⁴
Shareholders’ equity	-$805.0K⁵	-$5.4M⁶	$11.9M⁶	$61.8M⁷	$229.7M⁴	$132.4M⁴	$57.2M⁴
Shares outstanding	4.3M shares⁸	4.4M shares⁵	12.3M shares¹²	20.7M shares⁶	29.8M shares⁷	30.3M shares⁴	34.5M shares⁴

Cash from operations⁸⁵⁶⁷⁴-$77.0M in 2023

Capital spending⁵⁶⁷⁴$902.0K in 2023+7417% since 2018

Free cash flow⁵⁶⁷⁴-$77.9M in 2023+922% since 2018

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Cash from operations	$2.2K⁸	-$7.6M⁵	-$17.8M⁶	-$28.7M⁶	-$62.1M⁷	-$95.3M⁴	-$77.0M⁴
Depreciation and amortization					$100.0K⁷	$200.0K⁴	$200.0K⁴
Stock-based compensation					$13.3M⁷	$18.9M⁴	$18.6M⁴
Capital spending		$12.0K⁵	$210.0K⁶	$1.8M⁶	$2.7M⁷	$3.3M⁴	$902.0K⁴
Free cash flow		-$7.6M	-$18.0M	-$30.5M	-$64.8M	-$98.6M	-$77.9M
Cash from investing					-$12.5M⁷	-$4.3M⁴	$29.9M⁴
Cash from financing					$230.3M⁷	$917.0K⁴	$6.1M⁴

Compare DermTech, Inc. with another company

Leadership

Who has led DermTech, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

Chair

Rajiv Shukla2017

Chief financial officer

Chief operating officer

Claudia Ibarra2020–2023

20202025

Chief executive officerBret Christensen May 10, 2023 to May 10, 2023¹⁴
Chief executive officerJohn Dobak Sep 9, 2019 to Apr 6, 2023¹⁵
Chief executive officerRajiv Shukla Jun 19, 2017 to Jun 26, 2017¹⁶
ChairRajiv Shukla Jun 19, 2017 to Jun 26, 2017¹⁶
Chief financial officerSteven J. Kemper Sep 9, 2019 to Sep 9, 2019¹⁷
Chief financial officerKevin M. Sun Sep 25, 2019 to Jun 12, 2024¹⁸
Chief financial officerCraig Pollak Jun 19, 2017 to Jun 19, 2017¹⁹
Chief operating officerClaudia Ibarra Mar 30, 2020 to Dec 11, 2023²⁰

Board members and other officers (20)

Chief Commercial OfficerMark Bryan Aguillard Sep 22, 2023 to Sep 22, 2023²¹
Chief Medical OfficerBurkhard Jansen Sep 9, 2019 to Mar 31, 2021²²
Chief Commercial OfficerTodd Michael Wood Sep 9, 2019 to Jun 14, 2023²³
Chief Scientific OfficerZuxu Yao Sep 9, 2019 to Jun 26, 2020²⁴
Board memberBret Christensen May 10, 2023 to May 10, 2023¹⁴
Board memberKirk Malloy Jul 20, 2022 to Jun 5, 2023²⁵
Board memberMark Christopher Capone Jul 20, 2022 to Jun 5, 2023²⁶
Board memberMonica Tellado Jul 7, 2021 to May 31, 2022²⁷
Board memberNathalie Gerschtein Keraudy Oct 7, 2021 to Jun 5, 2023²⁸
Board memberCynthia Collins Sep 9, 2019 to Jun 5, 2023²⁹
Board memberEnrico Picozza Sep 9, 2019 to May 28, 2021³⁰
Board memberGene Salkind Sep 9, 2019 to Feb 3, 2020³¹
Board memberHerm Rosenman Sep 9, 2019 to Jun 5, 2023³²
Board memberJohn Dobak Sep 9, 2019 to Apr 6, 2023¹⁵
Board memberMatthew L. Posard Sep 9, 2019 to Jun 5, 2023³³
Board memberScott R. Pancoast Sep 9, 2019 to Jul 2, 2021³⁴
Board memberAlan Rosling Jun 19, 2017 to Jun 19, 2017³⁵
Board memberJohn Joseph Alexander Jun 19, 2017 to Jun 19, 2017³⁶
Board memberKewal Handa Jun 19, 2017 to Jun 19, 2017³⁷
General counselRamin Akhavan Jan 5, 2021 to Jun 7, 2024³⁸

Former names

Constellation Alpha Capital Corp.Sep 24, 2015 to Sep 5, 2019²

Timeline

May 10, 2023New chief executive Bret Christensen becomes CEO¹⁴
Sep 9, 2019New chief executive John Dobak becomes CEO¹⁵
Jun 19, 2017New chief executive Rajiv Shukla becomes CEO¹⁶

Filings

164 filings to the SEC since October 2021: 4 annual reports, 8 quarterly reports, 30 major events, 90 insider forms, 11 large holders, 21 other. The latest 20:

Apr 2, 202615-12G EDGAR
Jun 20, 20248-K EDGAR
Jun 18, 20248-K EDGAR
Jun 12, 20244 EDGAR
Jun 7, 20244 EDGAR
Jun 7, 20244 EDGAR
May 17, 20248-K EDGAR
May 15, 202410-Q EDGAR
May 14, 20248-K EDGAR
May 10, 20248-K EDGAR
Apr 26, 202410-K/A EDGAR
Apr 26, 2024SC 13G EDGAR
Apr 18, 20248-K EDGAR
Apr 16, 20248-K EDGAR
Mar 12, 20244 EDGAR
Mar 12, 20244/A EDGAR
Mar 7, 20244 EDGAR
Mar 7, 20244 EDGAR
Mar 7, 2024S-8 EDGAR
Feb 29, 202410-K EDGAR

The 164 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

73 open-market trades by officers, directors and large owners since October 2021: 2 buys and 71 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Dec 11, 2023	Sun Kevin MChief Financial Officer	Sale	447	$1.45	$648	Form 4
Dec 11, 2023	Ibarra ClaudiaChief Operating Officer	Sale	331	$1.45	$480	Form 4
Dec 8, 2023	Ibarra ClaudiaChief Operating Officer	Sale	2,607	$1.41	$3.7K	Form 4
Dec 7, 2023	Sun Kevin MChief Financial Officer	Sale	4,979	$1.53	$7.6K	Form 4
Dec 7, 2023	Ibarra ClaudiaChief Operating Officer	Sale	3,911	$1.53	$6.0K	Form 4
Dec 7, 2023	Akhavan RaminGeneral Counsel	Sale	3,768	$1.53	$5.8K	Form 4
Sep 11, 2023	Sun Kevin MChief Financial Officer	Sale	436	$1.89	$824	Form 4
Sep 11, 2023	Ibarra ClaudiaChief Operating Officer	Sale	322	$1.89	$609	Form 4
Sep 8, 2023	Sun Kevin MChief Financial Officer	Sale	9,180	$1.93	$17.7K	Form 4
Sep 8, 2023	Ibarra ClaudiaChief Operating Officer	Sale	7,378	$1.93	$14.2K	Form 4
Sep 8, 2023	Akhavan RaminGeneral Counsel	Sale	4,531	$1.93	$8.7K	Form 4
Jun 12, 2023	Wood Todd MichaelChief Commercial Officer	Sale	350	$2.85	$998	Form 4
Jun 12, 2023	Sun Kevin MChief Financial Officer	Sale	437	$2.85	$1.2K	Form 4
Jun 12, 2023	Ibarra ClaudiaChief Operating Officer	Sale	322	$2.85	$918	Form 4
Jun 8, 2023	Sun Kevin MChief Financial Officer	Sale	2,828	$2.61	$7.4K	Form 4
Jun 8, 2023	Ibarra ClaudiaChief Operating Officer	Sale	2,371	$2.61	$6.2K	Form 4
Jun 7, 2023	Wood Todd MichaelChief Commercial Officer	Sale	4,992	$2.53	$12.6K	Form 4
Jun 7, 2023	Sun Kevin MChief Financial Officer	Sale	4,988	$2.53	$12.6K	Form 4
Jun 7, 2023	Ibarra ClaudiaChief Operating Officer	Sale	3,916	$2.53	$9.9K	Form 4
Jun 7, 2023	Akhavan RaminGeneral Counsel	Sale	3,776	$2.53	$9.6K	Form 4

All 73 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

VAN HERK INVESTMENTS B.V.SC 13G, 3 filings Jun 16, 2023 to Apr 26, 2024³⁹
RTW INVESTMENTS, LPSC 13D/A, 2 filings Nov 8, 2022 to Dec 12, 2023⁴⁰
Casdin Capital, LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023⁴¹
State Street CorporationSC 13G/A, 4 filings Feb 10, 2022 to Feb 3, 2023⁴²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDermTech, Inc. filings on SEC EDGAR
2
SEC EDGARDermTech, Inc. filings on SEC EDGAR
3
SEC EDGARDermTech, Inc. annual report, Item 1 (Business)
4
SEC EDGARDermTech, Inc. 10-K for fiscal 2023
5
SEC EDGARDermTech, Inc. 10-K for fiscal 2018
6
SEC EDGARDermTech, Inc. 10-K for fiscal 2019
7
SEC EDGARDermTech, Inc. 10-K for fiscal 2021
8
SEC EDGARDermTech, Inc. 10-K for fiscal 2017
9
SEC EDGARDermTech, Inc. 10-Q for fiscal 2023
10
SEC EDGARDermTech, Inc. 10-Q for fiscal 2023
11
SEC EDGARDermTech, Inc. 10-Q for fiscal 2024
12
SEC EDGARDermTech, Inc. 10-K for fiscal 2019
13
SEC EDGARDermTech, Inc. 10-K for fiscal 2017
14
SEC EDGARBret Christensen, Chief executive officer
15
SEC EDGARJohn Dobak, Chief executive officer
16
SEC EDGARRajiv Shukla, Chief executive officer
17
SEC EDGARSteven J. Kemper, Chief financial officer
18
SEC EDGARKevin M. Sun, Chief financial officer
19
SEC EDGARCraig Pollak, Chief financial officer
20
SEC EDGARClaudia Ibarra, Chief operating officer
21
SEC EDGARMark Bryan Aguillard, Chief Commercial Officer
22
SEC EDGARBurkhard Jansen, Chief Medical Officer
23
SEC EDGARTodd Michael Wood, Chief Commercial Officer
24
SEC EDGARZuxu Yao, Chief Scientific Officer
25
SEC EDGARKirk Malloy, Board member
26
SEC EDGARMark Christopher Capone, Board member
27
SEC EDGARMonica Tellado, Board member
28
SEC EDGARNathalie Gerschtein Keraudy, Board member
29
SEC EDGARCynthia Collins, Board member
30
SEC EDGAREnrico Picozza, Board member
31
SEC EDGARGene Salkind, Board member
32
SEC EDGARHerm Rosenman, Board member
33
SEC EDGARMatthew L. Posard, Board member
34
SEC EDGARScott R. Pancoast, Board member
35
SEC EDGARAlan Rosling, Board member
36
SEC EDGARJohn Joseph Alexander, Board member
37
SEC EDGARKewal Handa, Board member
38
SEC EDGARRamin Akhavan, General counsel
39
SEC EDGARVAN HERK INVESTMENTS B.V. SC 13G on DermTech, Inc.
40
SEC EDGARRTW INVESTMENTS, LP SC 13D/A on DermTech, Inc.
41
SEC EDGARCasdin Capital, LLC SC 13G/A on DermTech, Inc.
42
SEC EDGARState Street Corporation SC 13G/A on DermTech, Inc.